Welcome to LookChem.com Sign In|Join Free

CAS

  • or

263754-57-0

Post Buying Request

263754-57-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

263754-57-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 263754-57-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,3,7,5 and 4 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 263754-57:
(8*2)+(7*6)+(6*3)+(5*7)+(4*5)+(3*4)+(2*5)+(1*7)=160
160 % 10 = 0
So 263754-57-0 is a valid CAS Registry Number.

263754-57-0Downstream Products

263754-57-0Relevant articles and documents

Cross-Coupling Reactions of Aryldiazonium Salts with Allylsilanes under Merged Gold/Visible-Light Photoredox Catalysis

Akram, Manjur O.,Mali, Pramod S.,Patil, Nitin T.

supporting information, p. 3075 - 3078 (2017/06/23)

A method for the cross-coupling reactions of aryldiazonium salts with trialkylallylsilanes via merged gold/photoredox catalysis is described. The reaction is proposed to proceed through a photoredox-promoted generation of an electrophilic arylgold(III) intermediate that undergoes transmetalation with allyltrimethylsilane to form allylarenes.

Nickel-catalyzed heck-type reactions of benzyl chlorides and simple olefins

Matsubara, Ryosuke,Gutierrez, Alicia C.,Jamison, Timothy F.

supporting information; experimental part, p. 19020 - 19023 (2011/12/21)

Nickel-catalyzed intermolecular benzylation and heterobenzylation of unactivated alkenes to provide functionalized allylbenzene derivatives are described. A wide range of both the benzyl chloride and alkene coupling partners are tolerated. In contrast to analogous palladium-catalyzed variants of this process, all reactions described herein employ electronically unbiased aliphatic olefins (including ethylene), proceed at room temperature, and provide 1,1-disubstituted olefins over the more commonly observed 1,2-disubstituted olefins with very high selectivity.

Prostaglandin receptor ligands

-

, (2008/06/13)

Compounds and methods for treating prostaglandin mediated diseases, and certain pharmaceutical compositions thereof are disclosed. The compounds are represented by formula II: Ar1—W—Ar2—X—Q??II The compounds of the invention are structurally different from NSAIDs and opiates, and are antagonists of the pain and inflammatory effects of E-type prostaglandins.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 263754-57-0